With drug discovery increasingly dependent on computing resources, pharmaceutical giant Novartis wanted a cost-effective way to expand its R&D compute power. By linking 2,700 of its researchers?????????????????????????????????? PCs in a high-performance grid that delivers an extra 5+ teraflops of compute power, it enabled scientists to enlarge the scope of their research. Novartis?????????????????????????????????? US $400,000 investment in grid technologies has generated savings of $2M and produced affordable computing resources that will help the company accelerate the development of life-saving new drugs. Novartis expects its PC standardization to save it an estimated $200M in total cost of ownership (TCO) over three years. New PCs can be added to the grid, further enhancing Novartis?????????????????????????????????? return on its PC investments. Topics: Pharmaceutical Industry Grid Computing Total Cost of Ownership Desktop PC Management Network Management Data Center Management